Hangzhou Tongee Medical Technology Co., Ltd. is a national innovative enterprise dedicated to developing digestive tract interventional therapy and related medical devices for the management of metabolic diseases. Our vision is to develop new approaches for the treatment of metabolic diseases. Our mission is to relieve patients with metabolic diseases around the world from their pain and help them regain health and happiness. We have developed multiple new medical technologies to treat various metabolic diseases such as obesity, type 2 diabetes, and nonalcoholic fatty liver. In addition, we have established multiple technology platforms and ISO13485-certified R&D, quality, manufacturing, and supply chain management system. By the end of 2021, there are nearly 10 projects in the company pipeline and over 50 patent applications in Tongee. Several products are undergoing clinical studies of different phases in over 20 well-known hospitals. Tongee is an innovation-driven and doctor- and patient-centered company dedicated to ushering in a new era of interventional treatment for metabolic diseases!